The -308G/A of Tumor Necrosis Factor (TNF)-α and 825C/T of Guanidine Nucleotide Binding Protein 3 (GNB3) are Associated with the Onset of Acute Myocardial Infarction and Obesity in Taiwan
Acute myocardial infarction is a highly prevalent cardiovascular disease in Taiwan. Among several etiological risk factors, obesity and inflammation are strongly associated with the frequency of hypertension, cardiovascular disease, diabetes, and myocardial infarction. To discriminate obesity- and inflammation-related genes and the onset of acute myocardial infarction (AMI), a case-control study was conducted to investigate the association of the -308G/A polymorphisms of tumor necrosis factor (TNF)-α and the C825T polymorphism of guanidine nucleotide binding protein 3 (GNB3 ) with the onset of AMI among Taiwanese cohorts. A total of 103 AMI patients and 163 matched normal control samples were enrolled in the present study. The genomic DNA was extracted and subjected into polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis. An association between the A homozygosity of the TNF-α-308G/A polymorphism and the onset of AMI was observed among the male subjects ( p = 0.026; Spearman index = 0.200, p = 0.008). An association between the T homozygosity of GNB3 C825T polymorphism and obesity was also observed (Fisher’s exact, p = 0.009). The TT genotype has a protective effect against acquiring AMI among the obese female population in Taiwan (Fisher’s exact, p = 0.032). In conclusion, TNF-α-308G/A and the GNB3 C825T polymorphisms are associated with obesity and AMI in the Taiwanese population.
References
[1]
Wang, Y.C.; Hwang, J.J.; Hung, C.S.; Kao, H.L.; Chiang, F.T.; Tseng, C.D. Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction. J. Formos. Med. Assoc 2006, 105, 451–458.
[2]
Liu, P.Y.; Chen, J.H.; Li, Y.H.; Wu, H.L.; Shi, G.Y. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb. Haemost 2003, 90, 132–139.
[3]
Vendrell, J.; Fernandez-Real, J.M.; Gutierrez, C.; Zamora, A.; Simon, I.; Bardaji, A.; Ricart, W.; Richart, C. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003, 167, 257–264.
[4]
Bernard, V.; Pillois, X.; Dubus, I.; Benchimol, D.; Labouyrie, J.P.; Couffinhal, T.; Coste, P.; Bonnet, J. The -308 G/A tumor necrosis factor-alpha gene dimorphism: A risk factor for unstable angina. Clin. Chem. Lab. Med 2003, 41, 511–516.
[5]
Dedoussis, G.V.; Panagiotakos, D.B.; Vidra, N.V.; Louizou, E.; Chrysohoou, C.; Germanos, A.; Mantas, Y.; Tokmakidis, S.; Pitsavos, C.; Stefanadis, C. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: The CARDIO2000-GENE Study. Genet. Med 2005, 7, 411–416.
[6]
Antonicelli, R.; Olivieri, F.; Cavallone, L.; Spazzafumo, L.; Bonafe, M.; Marchegiani, F.; Cardelli, M.; Galeazzi, R.; Giovagnetti, S.; Perna, G.P.; et al. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis 2005, 16, 489–493.
[7]
Kang, M.; Chung, K.Y.; Walker, J.W. G-protein coupled receptor signaling in myocardium: not for the faint of heart. Physiology (Bethesda) 2007, 22, 174–184.
[8]
Schunkert, H.; Hense, H.W.; Doring, A.; Riegger, G.A.; Siffert, W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998, 32, 510–513.
[9]
Siffert, W.; Rosskopf, D.; Siffert, G.; Busch, S.; Moritz, A.; Erbel, R.; Sharma, A.M.; Ritz, E.; Wichmann, H.E.; Jakobs, K.H.; et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet 1998, 18, 45–48.
[10]
Siffert, W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu. Rev. Med 2005, 56, 17–28.
[11]
Wascher, T.C.; Paulweber, B.; Malaimare, L.; Stadlmayr, A.; Iglseder, B.; Schmoelzer, I.; Renner, W. Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosis. Stroke 2003, 34, 605–609.
[12]
Zhang, L.; Zhang, H.; Sun, K.; Song, Y.; Hui, R.; Huang, X. The 825C/T polymorphism of G-protein beta3 subunit gene and risk of ischaemic stroke. J. Hum. Hypertens 2005, 19, 709–714.
[13]
Klintschar, M.; Stiller, D.; Schwaiger, P.; Kleiber, M. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: Association with unexpected death from acute myocardial infarction and increased heart weight. Forensic. Sci. Int 2005, 153, 142–146.
Dong, Y.; Zhu, H.; Sagnella, G.A.; Carter, N.D.; Cook, D.G.; Cappuccio, F.P. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999, 34, 1193–1196.
[16]
Huang, X.; Ju, Z.; Song, Y.; Zhang, H.; Sun, K.; Lu, H.; Yang, Z.; Jose, P.A.; Zhou, G.; Wang, M.; et al. Lack of association between the G protein beta3 subunit gene and essential hypertension in Chinese: a case-control and a family-based study. J. Mol. Med. (Berl.) 2003, 81, 729–735.
[17]
Li, B.; Ge, D.; Wang, Y.; Zhao, W.; Zhou, X.; Gu, D.; Chen, R. G protein beta 3 subunit gene variants and essential hypertension in the northern Chinese Han population. Ann. Hum. Genet 2005, 69, 468–473.
[18]
Siffert, W.; Forster, P.; Jockel, K.H.; Mvere, D.A.; Brinkmann, B.; Naber, C.; Crookes, R.; Du, P.H.A.; Epplen, J.T.; Fridey, J.; et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J. Am. Soc. Nephrol 1999, 10, 1921–1930.
[19]
Wang, Y.C.; Chen, C.C.; Zhang, W.D.; Zhang, S.K.; Chang, F.H.; Hsu, L.S. The 252A/G and 804C/A polymorphisms of Lymphotoxin-alpha is associated to onset of acute myocardial infarction in Taiwan. LabMedicine 2010, 41, 220–225.
[20]
Govan, V.A.; Constant, D.; Hoffman, M.; Williamson, A.L. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 2006, 6, 24.
[21]
Cambien, F.; Poirier, O.; Mallet, C.; Tiret, L. Coronary heart disease and genetics in epidemiologist’s view. Mol. Med. Today 1997, 3, 197–203.
[22]
Incalcaterra, E.; Hoffmann, E.; Averna, M.R.; Caimi, G. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol 2004, 52, 287–312.
[23]
Ritchie, S.A.; Connell, J.M. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr. Metab. Cardiovasc. Dis 2007, 17, 319–326.
[24]
Elkind, M.S. Inflammation, atherosclerosis, and stroke. Neurologist 2006, 12, 140–148.
[25]
Chen, D.; Assad-Kottner, C.; Orrego, C.; Torre-Amione, G. Cytokines and acute heart failure. Crit. Care Med 2008, 36, S9–S16.
[26]
Abraham, L.J.; Kroeger, K.M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol 1999, 66, 562–566.
[27]
Padovani, J.C.; Pazin-Filho, A.; Simoes, M.V.; Marin-Neto, J.A.; Zago, M.A.; Franco, R.F. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb. Res 2000, 100, 263–269.
[28]
Koch, W.; Kastrati, A.; Bottiger, C.; Mehilli, J.; von Beckerath, N.; Schomig, A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001, 159, 137–144.
[29]
Antonicelli, R.; Olivieri, F.; Bonafe, M.; Cavallone, L.; Spazzafumo, L.; Marchegiani, F.; Cardelli, M.; Recanatini, A.; Testarmata, P.; Boemi, M.; et al. The interleukin-6 -174 G > C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int. J. Cardiol 2005, 103, 266–271.
[30]
Sheu, W.H.; Lee, W.J.; Lin, L.Y.; Chang, R.L.; Chen, Y.T. Tumor necrosis factor alpha -238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism 2001, 50, 1447–1451.
[31]
Shiau, M.Y.; Wu, C.Y.; Huang, C.N.; Hu, S.W.; Lin, S.J.; Chang, Y.H. TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 2003, 61, 393–397.
Stefan, N.; Stumvoll, M.; Machicao, F.; Koch, M.; Haring, H.U.; Fritsche, A. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity. Obes. Res 2004, 12, 679–683.
[34]
Yamamoto, M.; Abe, M.; Jin, J.J.; Wu, Z.; Tabara, Y.; Mogi, M.; Kohara, K.; Miki, T.; Nakura, J. Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese. Biochem. Biophys. Res. Commun 2004, 316, 744–748.
[35]
Naber, C.K.; Husing, J.; Wolfhard, U.; Erbel, R.; Siffert, W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension 2000, 36, 986–989.
[36]
Hanon, O.; Luong, V.; Mourad, J.J.; Bortolotto, L.A.; Safar, M.; Girerd, X. Association between the G protein beta3 subunit 825t allele and radial artery hypertrophy. J. Vasc. Res 2002, 39, 497–503.
[37]
Kiani, J.G.; Saeed, M.; Parvez, S.H.; Frossard, P.M. Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes. Neuro. Endocrinol. Lett 2005, 26, 87–88.
[38]
Hengstenberg, C.; Schunkert, H.; Mayer, B.; Doring, A.; Lowel, H.; Hense, H.W.; Fischer, M.; Riegger, G.A.; Holmer, S.R. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc. Res 2001, 49, 820–827.
[39]
Klintschar, M.; Stiller, D.; Schwaiger, P.; Kleiber, M. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: Association with unexpected death from acute myocardial infarction and increased heart weight. Forensic. Sci. Int 2005, 153, 142–146.
